Creatine kinase and SLCO1B1 RS4363657 polymorphism in Malaysian dyslipidaemic patients prescribed with statin drugs
Background: Statin, a first line treatment for dyslipidaemia has reduced patient compliance and is underprescribed because of its side effect of muscle toxicity. The incidence of statin-induced muscle toxicity ranges from 1% to 7%, whereas severe muscle toxicity occurs in up to 0.5% of patients....
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Thesis |
| Jezik: | English |
| Izdano: |
2016
|
| Online dostop: | http://ethesis.upm.edu.my/id/eprint/16617/1/FPSK%20%28m%29%202016%2037%20T.pdf |
| Oznake: |
Označite
Brez oznak, prvi označite!
|